Investing.com - Biovie (NASDAQ: BIVI) reported first quarter EPS of $-0.25, worse than the analyst estimate of $-0.25. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Biovie's stock price closed at $3.53. It is down -18.10% in the last 3 months and up 37.89% in the last 12 months.
Biovie saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Biovie's stock price’s past reactions to earnings here.
According to InvestingPro, Biovie's Financial Health score is "weak performance".
Check out Biovie's recent earnings performance, and Biovie's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar